Literature DB >> 15245809

Non-invasive urothelial neoplasms: according to the most recent WHO classification.

Antonio Lopez-Beltran1, Rodolfo Montironi.   

Abstract

The key points of the latest World Health Organization (WHO) classification of non-invasive urothelial tumors are: the description of the categories has been expanded in the current version to improve their recognition; one group (papillary urothelial neoplasm of low malignant potential) with particularly good prognosis does not carry the label of 'cancer'; it avoids use of ambiguous grading such as grade 1/2 or 2/3 (according to the WHO classification published in 1973, i.e., 1973 WHO classification); the group of non-invasive high grade carcinoma is large enough to contain virtually all those tumors that have biological properties (and a high level of genetic instability) similar to those seen in invasive urothelial carcinoma. This scheme is meant to replace the 1973 WHO classification. Changes in classification have their own inherent problems, tending to lead to confusion, at least for a period of time. From the practical point of view, the use of both the 1973 and the latest WHO classifications is recommended until the latter is sufficiently validated.

Entities:  

Mesh:

Year:  2004        PMID: 15245809     DOI: 10.1016/j.eururo.2004.03.017

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  38 in total

Review 1.  [Photodynamic therapy of bladder cancer. A new option].

Authors:  J Neuhaus; S Schastak; M Berndt; J Walther; A Dietel; N Sieger; J-U Stolzenburg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

2.  Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.

Authors:  A Quintero; J Alvarez-Kindelan; R J Luque; R Gonzalez-Campora; M J Requena; R Montironi; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

Review 3.  Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.

Authors:  Andrew Rh Shepherd; Emily Shepherd; Nicholas R Brook
Journal:  Cochrane Database Syst Rev       Date:  2017-03-08

4.  Expression and clinical significance of androgen receptor in bladder cancer: A meta-analysis.

Authors:  Jinbo Chen; Yu Cui; Peng Li; Longfei Liu; Chao Li; Xiongbing Zu
Journal:  Mol Clin Oncol       Date:  2017-08-23

5.  Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study.

Authors:  Michael D Bell; Faysal A Yafi; Fadi Brimo; Jordan Steinberg; Armen G Aprikian; Simon Tanguay; Wassim Kassouf
Journal:  World J Urol       Date:  2016-02-23       Impact factor: 4.226

6.  Surgical management of bladder transitional cell carcinoma in a vesicular diverticulum: case report.

Authors:  Omer A Raheem; Behdad Besharatian; David P Hickey
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

7.  [Non-invasive and invasive urothelial tumours: special challenges in uropathological diagnostics].

Authors:  N T Gaisa; K Lindemann-Docter
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

Review 8.  [Urinary bladder tumours. The new 2004 WHO classification].

Authors:  M Seitz; D Zaak; R Knüchel-Clarke; C Stief
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

Review 9.  [Multimodal therapy for bladder sparing with high grade bladder tumors].

Authors:  P J Goebell; W Legal; C Weiss; R Fietkau; B Wullich; S Krause
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

10.  [Diagnosis of urothelial carcinoma].

Authors:  A Karl; D Zaak; D Tilki; E Hungerhuber; M Staehler; S Denzinger; P Stanislaus; S Tritschler; F Strittmatter; C Stief; M Burger
Journal:  Urologe A       Date:  2008-03       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.